RPL7 Antibody

Western Blot: RPL7 Antibody [NB100-2268]

Western Blot: RPL7 Antibody [NB100-2268] - Staufen1 co-fractionates with Gag and vRNA in gradient density fractionation analyses. HeLa cells were either mock transfected with empty vector, pcDNA3, or with a plasmid that expresses Staufen1-HA. The transfected cells were collected 24?h later, lysed and were either mock-treated or treated with RNAse A. The lysates were then fractionated on 5-50% sucrose gradients and 20 fractions were collected for further analysis by western blotting for viral and host proteins, as indicated. HIV-1 viral genomic RNA (vRNA, 9?kb) was assessed in each fraction by slot blot analysis. TL represents the total lysates. Image collected and cropped by CiteAb from the following publication (https://www.frontiersin.org/Journal/10.3389/fmicb.2012.00367/full), licensed under a CC-BY license.

Western Blot: RPL7 Antibody [NB100-2268]

Western Blot: RPL7 Antibody [NB100-2268] - Detection of Human and Mouse RPL7 on HeLa whole cell lysate using NB100-2268. RPL7 was immunoprecipitated by rabbit anti-RPL7 antibody NB100-2269.

Western Blot: RPL7 Antibody [NB100-2268]

Western Blot: RPL7 Antibody [NB100-2268] - Staufen1 co-fractionates with Gag and vRNA in gradient density fractionation analyses. HeLa cells were co-transfected with pNL 4-3 and Staufen1-HA. The presence of Staufen1-HA, precursor Gag and p24 were assessed in each fraction by western blotting analysis. HIV-1 viral genomic RNA (9?kb, vRNA) was assessed in each fraction by slot blot analysis. Staufen1, Gag and vRNA were quantitated in each fraction by densitometry and relative levels are depicted for each fraction (Blue: Staufen1-HA, Red: Gag, Green-vRNA). Image collected and cropped by CiteAb from the following publication (https://www.frontiersin.org/Journal/10.3389/fmicb.2012.00367/full), licensed under a CC-BY license.